Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,355 | 4,914 | 2,768 | 7,453 | 3,573 |
| TOTAL | $4,386 | $6,714 | $4,455 | $9,373 | $4,893 |
| Non-Current Assets | |||||
| PPE Net | 65 | 92 | 121 | 152 | 179 |
| Investments And Advances | 112 | 112 | 112 | 112 | 112 |
| Other Non-Current Assets | 262 | 372 | 482 | 590 | 698 |
| TOTAL | $438 | $576 | $714 | $854 | $989 |
| Total Assets | $4,825 | $7,291 | $5,170 | $10,228 | $5,882 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,275 | 2,367 | 3,051 | 5,139 | 3,044 |
| TOTAL | $3,502 | $2,706 | $3,491 | $5,598 | $3,523 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 27 | 54 | 82 |
| Other Non-Current Liabilities | 0 | 0 | 38 | 190 | 266 |
| TOTAL | $N/A | $N/A | $38 | $190 | $266 |
| Total Liabilities | $3,502 | $2,706 | $3,529 | $5,788 | $3,789 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19 | 7 | 6 | 1 | 0 |
| Common Shares | 1 | 1 | 0 | 1 | 0 |
| Retained earnings | -54,934 | -49,743 | -46,416 | -42,329 | -37,029 |
| TOTAL | $1,322 | $4,584 | $1,641 | $4,440 | $2,093 |
| Total Liabilities And Equity | $4,825 | $7,291 | $5,170 | $10,228 | $5,882 |